The Animal Health Trust has announced a research project which aims to improve the way dogs are treated for cancer. As part of the project, the charity is appealing to veterinary practices to send samples taken from dogs diagnosed with cancer.

Using the…

A research project funded by equine charity The Horse Trust has succeeded in killing equine sarcoid cells in vitro by silencing a gene in the virus that causes sarcoids. The researchers are now hoping to obtain funding for clinical trials using the new…

A research project funded by The Horse Trust has found that various types of ocular tumours can be successfully treated with mitomycin C, a cytotoxic antibiotic isolated from a bacterium.

The research concludes that mitomycin C offers a safe and cost…

The American Kennel Club Canine Health Foundation has awarded Dr. Bruce Smith, director of the Auburn University Research Initiative in Cancer, a two-year grant totaling $118,848 to test a new therapy for treating bone cancer in dogs.

According…

A new study carried out by researchers at the Yale School of Medicine and Yale Cancer Center, published in the Journal of the National Cancer Institute, has found that human cancer patients who use alternative medicine are up to 5.7 times more likely to die…

The RVC has published a new study which has revealed several risk factors for canine lipomas, fatty masses which because of their large size and rapid growth often cause extreme and long-term anxiety to the owners of affected dogs.

The College says t…

The Animal Health Trust, in collaboration with the University of Cambridge is going to conduct new research to enable the creation of a blood test to identify Flatcoated Retrievers with early stage histiocytic sarcoma.

The charity says that although histiocytic…

Viennese biotech company BlueSky Immunotherapies says it has used its viral vector platform delNS to treat sarcoids in horses successfully, paving the way for a new cancer therapy in humans.

BlueSky says that conventional treatment for equine sarcoids…

Virbac, maker of Stelfonta, has released the result of a quick poll of vets at the London Vet Show who said that on average, they had diagnosed 7.03 mast cell tumours (MCTs) in the last year, when earlier research had showed the figure should be more…

The Queen’s Veterinary School Hospital (QVSH) at the University of Cambridge has joined forces with the Wellcome Sanger Institute to conduct research into osteosarcoma (OSA) in dogs, and is looking for research participants.

The new study will examine…